Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Measuring CTCs in CTCL

Maarten Vermeer • 15 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, discusses novel methods to identify and quantify circulating tumor cells (CTCs) in patients with cutaneous T-cell lymphoma (CTCL), commenting on the role of markers in detecting cell surface protein heterogeneity. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Maarten Vermeer

0:55
Multimarker approach to CTC analysis in CTCL
Maarten Vermeer • 15 Oct 2021
1:42
The benefits of improving tumor cell quantification in CTCL
Maarten Vermeer • 15 Oct 2021
1:10
Unmet needs for late-stage CTCL
Maarten Vermeer • 15 Oct 2021
1:04
Unmet needs in early-stage mycosis fungoides
Maarten Vermeer • 15 Oct 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals